630 results
RIVER: Rivaroxaban for valvular heart disease and atrial fibrillation
05 Sep 2023
Alex Sticchi provides his take on the results of the RIVER trial, which were presented by Pedro Gabriel Barros E Silva during the ESC 2023 congress in Amsterdam.
Rivaroxaban versus Warfarin in Patients with Bioprosthetic Valves According to Valvular Heart Disease Etiology, and Thrombotic and Bleeding Risks: Insights from...
Author
TEER versus mitral surgery: Data from a nationwide analysis
26 Aug 2023
Alessandro Sticchi interviews Pierre Deharo about the design and results of the study he presented during the ESC Congress 2023 in Amsterdam.
When comparing long-term outcomes of transcatheter edge-to-edge repair (TEER) versus isolated mitral valve repair surgery, the analysis revealed that cardiovascular death was lower among...
Author
Author
What are the essential skillsets for aspiring transcatheter edge-to-edge mitral valve repair operators?
17 May 2023 – From EuroPCR 2023
Rebecca Hahn, interventional echocardiographer, and Sam Dawkins, interventional cardiologist, look at the skills a good fellow needs to become an excellent interventional cardiologist, particularly in relation to mitral interventions.
Mastery of imaging and the three-dimensional nature of the heart seems to be the key to success, but...
These papers changed my practice!
18 May 2023 – From EuroPCR 2023
Consult this session if you want to reflect on practical teachings from key papers of leading journals in 2022, to watch real cases translating science into practice, and to meet the editors of EuroIntervention and JACC: Cardiovascular Interventions.
Valvular heart disease: novel transcatheter approaches
18 May 2023 – From EuroPCR 2023
Explore this thrilling session on transcatheter approaches for valvular heart disease, featuring the latest advancements, emerging techniques, and revolutionary research. Join your peer as they present novel strategies and devices aimed at improving valvular disease management.
All you need to know about transcatheter treatment solutions for mitral regurgitation
18 May 2023 – From EuroPCR 2023
Consult this session for a comprehensive understanding of mitral regurgitation including anatomy, pathophysiology, imaging interpretation for diagnosis, intervention selection and procedure guidance, and identifying future unmet needs, illustrated with a series of case examples.
Innovations in TMVR and Intrepid trial updates
18 May 2023 – From EuroPCR 2023
This session explores the innovations in Transcatheter Mitral Valve replacement, with a special focus on the updates from the INTREPID and APOLLO EU trial, as well as patient benefits through case studies.
Knocking mitral regurgitation down to improve outcomes: earlier is better, but better late than never! (Episode 2: the left side)
18 May 2023 – From EuroPCR 2023
Help optimize your patients' prognosis by attending this session! You'll learn how proper patient selection and timely interventions lead to lasting results and how to use the latest real-world registry data to gain insight into the safety and effectiveness of M TEER.
Increase the complexity: multivalvular coronary interventions
17 May 2023 – From EuroPCR 2023
Investigate the increasing complexity of multivalvular coronary interventions in this insightful case-based presentation. Witness the complex challenges faced and discover the innovative approaches used to navigate the complex procedures.
EuroPCR 2023 Hotlines/Late-Breaking Trials: mitral and tricuspid valves disease
17 May 2023 – From EuroPCR 2023
The presenters share their views on a range of essays and studies. Join them for an update on: Early experience with a d-shape, monoleaflet TMVR system; Outcomes of Mitral Valve-in-Valve, Mitral Valve-in-Ring and Valve-in-Mitral Annular; Calcification: prospective MITRAL; DRAGONFLY-DMR: transcatheter repair by DragonFly device in mitral...
